期刊文献+

外周血循环肿瘤细胞的检测及其临床意义 被引量:11

原文传递
导出
摘要 恶性肿瘤的转移是一个涉及多步骤多因素的复杂过程,首先具有转移潜能的肿瘤细胞脱离原发病灶,以极少的数量转移到血液、骨髓、淋巴结或远处器官中,形成使用现有的常规的检测手段难以发现的肿瘤微转移(micrometastasis)。因此,早期发现微转移对肿瘤复发和预后的判断有重要意义。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第11期1053-1056,共4页 Chinese Journal of Laboratory Medicine
基金 国家高技术研究发展计划(863计划)资助项目(2011AA02A110) 卫生部医药卫生科技发展基金资助项目(WKJ2007-3-001) 国家重大新药创制科技重大专项(2012ZX09303012) 首都临床特色应用研究资助项目
  • 相关文献

参考文献38

  • 1Ashwoprth TR. A case of cancer in which cells similar to those inthe tumours were seen in the blood after death. Med J Australia,1869,14:146-147.
  • 2Dittmar T, Heyder C, Gloria-Maercker E,et al. Adhesionmolecules and chemok- ines : the navigation system for circulatingtumor ( stem) cells to metastasize in an organ-specific manner.Clin Exp Metastasis, 2008,25 :11-32.
  • 3Alunni-Fabbroni M,Sandri MT. Circulating tumors cells inclinical pratice : Methods of detection and possiblecharacterization. Methods, 2010,50:289-297.
  • 4Gertler R, Rosenberg R, Fuehrer K, et al. Detection ofcirculating tumor cells in blood using an optimized density gradientcentrifugation. Recent Results Cancer Res, 2003 ,162: 149-155.
  • 5Muller V,Stahmann N,Riethdorf S,et al. Circulating tumorcells in breast cancer : correlation to bone marrow micrometastases,heterogeneous response to systemic therapy and low proliferativeactivity. Clin Cancer Res, 2005,11:3678-3685.
  • 6Naume B,Borgen E, T0ssvik S,et al. Detection of isolated tumorcells in peripheral blood and in BM : evaluation of a newenrichment method. Cytolherapy, 2004,6:244-252.
  • 7Hayes GM, Busch R, Voogt J, et al. Isolation of malignant Bcells from patients with chronic lymphocytic leukemia ( CLL) foranalysis of cell proliferation : validation of a simplified methodsuitable for multi-center clinical studies. Leuk Res, 2010, 34:809-815.
  • 8Goeminne JC, Guillaume T, Symann M. Pitfalls in the detectionof disseminated non-heraatological tumor cells. Ann Oncol,2000,11:785-792.
  • 9Hsieh HB, Marrinucci D, Bethel K, et al. High speed detectionof circulating tumor cells. Biosens Bioelectron, 2006, 21 : 1893-1899.
  • 10Pachmann K, Dengler R, Lobodasch K,et al. An increase in cellnumber at coiftpletion of therapy may develop as an indicator ofearly relapse : quantification of circulating epithelial tumor cells(CETC) for monitoring of adjuvant therapy in breast cancer. JCancer Res Clin Oncol, 2008,134 :59-65.

同被引文献130

  • 1李晶,姜北,万鹏,李娜,王于理,巩平.晚期非小细胞肺癌患者循环肿瘤细胞检测的临床意义[J].中国全科医学,2013,16(27):3202-3204. 被引量:14
  • 2陈文彬,潘祥林.诊断学[M].第6版.北京:人民卫生出版社,2006.75-575.
  • 3Conrads TP,Fusaro VA,Ross S,et al.High-resolution serum proteomic features for ovarian cancer detection.Endocr Relat Cancer,2004,11:163-178.
  • 4Cubedo J,Padró T,García-Moll X,et al.Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction.J Prote Res,2011,10:211-220.
  • 5Mehan MR,Ayers D,Thirstrup D,et al.Protein signature of lung cancer tissues.PLoS One,2012,7:e35157.
  • 6Brown DL,Andreotti RF,Lee SI,et al.ACR appropriateness criteria.Ovarian cancer screening.Ultrasound Quarterly,2010,26:219-223.
  • 7Lorkova L,Pospisilova J,Lacheta J,et al.Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients:a potential biomarker identified by proteomics.Oncology Reports,2012,27:318-324.
  • 8Clarke CH,Yip C,Badgwell D,et al.Proteomic biomarkers apolipoprotein Al,truncated transthyretin,and connective tissue activating protein Ⅲ enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.Gynecologic Oncology,2011,122:548-553.
  • 9Matsubara J,Honda K,Ono M,et al.Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer.Cancer Epidemiol Biomarkers Prev,2011,20:160-171.
  • 10Pina F,Botelho F,Lopes T,et al.Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening? Eur J Cancer Prev,2013,in press.

引证文献11

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部